Home › Funds › Legacy Capital Group California, Inc. › IBRX

Legacy Capital Group California, Inc. position in IBRX

IMMUNITYBIO INC · Health Care

Legacy Capital Group California, Inc. reported holding 446,000 shares of IBRX (IMMUNITYBIO INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 1.26% of its reported portfolio and ranking #9 among its reported holdings. Legacy Capital Group California, Inc. has disclosed IBRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)446.00K sh
Reported value held$4.21M
Portfolio Weight1.26%
First reportedQ2 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Legacy Capital Group California, Inc.'s IBRX position evolved

Legacy Capital Group California, Inc. first disclosed a stake in IBRX in Q2 2026 at 446,000 shares (US$3.9M). The position peaked in Q3 2026 at 446,000 shares, worth US$4.2M. Across 2 filings, Legacy Capital Group California, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 446,000 shares valued at US$4.2M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 446.00K $3.90M New
Q3 2026 446.00K $4.21M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBRX and 13F data

IBRX (IMMUNITYBIO INC) is a Health Care company. 66 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), Sound Capital Solutions LLC (US$9.8M), Clearwater Capital Advisors, LLC (US$6.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBRX

All IBRX fund holders →

FAQ

How long has Legacy Capital Group California, Inc. held IBRX?

Legacy Capital Group California, Inc. has disclosed IBRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Legacy Capital Group California, Inc.'s current position in IBRX?

As of Q3 2026, Legacy Capital Group California, Inc. holds 446.00K shares of IBRX (IMMUNITYBIO INC), valued at $4.21M, representing 1.26% of its reported portfolio and ranking #9.

Has Legacy Capital Group California, Inc. been buying or selling IBRX?

In the latest 13F filing (Q3 2026), Legacy Capital Group California, Inc. held unchanged its position in IBRX. The position peaked in Q3 2026 at 446.00K shares.

Which other funds hold IBRX?

Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, Sound Capital Solutions LLC, Clearwater Capital Advisors, LLC, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.